Literature DB >> 7631601

Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty.

I Morishima1, T Sone, S Mokuno, S Taga, A Shimauchi, Y Oki, J Kondo, H Tsuboi, H Sassa.   

Abstract

The clinical significance of the angiographic no-reflow phenomenon was evaluated in 93 patients with acute myocardial infarction treated by percutaneous transluminal coronary angioplasty (PTCA). On the basis of the post-PTCA angiograms, patients were divided into three groups: normal angiogram (group 1, n = 65), slight no-reflow (group 2, n = 13), and severe no-reflow (group 3, n = 15). Regional wall motion in the chronic phase was depressed in groups 2 and 3 compared with group 1. The proportion of the area of the transmural infarction to that of the total infarction determined by scintigraphy was higher in groups 2 and 3 than in group 1. A significantly higher incidence of myocardial rupture and of death resulting from cardiac causes was observed in group 3 compared with group 1. The severity of this phenomenon immediately after an emergency PTCA correlated well with the severity of myocardial damage, with patients having severe no-reflow showing the poorest prognosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631601     DOI: 10.1016/0002-8703(95)90434-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  34 in total

1.  Intravascular ultrasound in the diagnosis of the no-reflow phenomenon after primary angioplasty for myocardial infarction.

Authors:  J Trevelyan; M Been
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  Reperfusion Injury: Basic Concepts and Protection Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

3.  Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.

Authors:  Li Dong-bao; Hua Qi; Liu Zhi; Wang Shan; Jin Wei-ying
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

4.  Coronary No-reflow Phenomenon.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-05

Review 5.  Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCA.

Authors:  A Vahanian; B Lung
Journal:  Drugs       Date:  1996       Impact factor: 9.546

6.  Multilayer longitudinal strain can help predict the development of no-reflow in patients with acute coronary syndrome without ST elevation.

Authors:  Adem Atıcı; Hasan Ali Barman; Emre Erturk; Omer Faruk Baycan; Serdar Fidan; Koray Celal Demirel; Ramazan Asoglu; Koray Demir; Fatih Ozturk; Ali Elitok; Erugrul Okuyan; Irfan Sahin
Journal:  Int J Cardiovasc Imaging       Date:  2019-05-15       Impact factor: 2.357

7.  Advances in Coronary No-Reflow Phenomenon-a Contemporary Review.

Authors:  Ahmadreza Karimianpour; Anbukarasi Maran
Journal:  Curr Atheroscler Rep       Date:  2018-07-05       Impact factor: 5.113

8.  Prediction of the no-reflow phenomenon during percutaneous coronary intervention using coronary computed tomography angiography.

Authors:  Hiroto Harigaya; Sadako Motoyama; Masayoshi Sarai; Kaori Inoue; Tomonori Hara; Masanori Okumura; Hiroyuki Naruse; Junnichi Ishii; Hitoshi Hishida; Yukio Ozaki
Journal:  Heart Vessels       Date:  2010-11-06       Impact factor: 2.037

9.  Evaluation of Short- and Long-Term Efficacy of Combined Intracoronary Administration of High-Dose Adenosine and Tirofiban during Primary Percutaneous Coronary Intervention.

Authors:  Yanbing Li; Qiang Li; Feiou Li; Min Zong; Guobin Miao; Xinchun Yang; Zichuan Tong; Jianjun Zhang
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

10.  A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts.

Authors:  Gaurav Swarnkar; Kunal Sharan; Jawed A Siddiqui; Jay Sharan Mishra; Kainat Khan; Mohd Parvez Khan; Varsha Gupta; Preeti Rawat; Rakesh Maurya; Anil K Dwivedi; Sabyasachi Sanyal; Naibedya Chattopadhyay
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.